Among them, the expression of XCR1 in normal samples of several tumor patients in T, N, and M stages was significantly different from that in advanced tumor stages, such as LUAD, LUSC, KIRC, COAD, LIHC, READ, and THCA (Figure 3B,D–H,J). This evidence concerns the gene XCR1 and neoplasm.